000078 海王生物
按盤價 
2.860 -0.070 (-2.389%)
2.860 -0.070 (-2.389%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 24,552,693 | -14.27% | 36,418,770 | 37,834,859 | 41,053,584 | 40,022,495 | |
| 減：營業總成本 | 24,375,199 | -13.99% | 36,503,984 | 37,782,459 | 40,327,347 | 39,140,690 | |
| 其中:營業成本 | 22,121,951 | -13.87% | 32,865,445 | 34,045,035 | 36,655,494 | 35,375,256 | |
| 財務費用 | 534,936 | -8.98% | 943,621 | 905,212 | 807,226 | 890,299 | |
| 資產減值損失 | 941 | -132.25% | (962,355) | (550,406) | (197,520) | (587,009) | |
| 公允價值變動收益 | 10,027 | 3,447.94% | 17,752 | 56,847 | 37,706 | 57,064 | |
| 投資收益 | (4,707) | -118.22% | (45,418) | (143,505) | 37,329 | 10,211 | |
| 其中：對聯營企業和合營企業的投資收益 | 13 | -99.31% | (26,996) | (106,917) | 46,675 | 54,635 | |
| 營業利潤 | 266,994 | -18.94% | (1,468,030) | (854,588) | 561,017 | 316,581 | |
| 利潤總額 | 268,878 | -21.37% | (1,458,474) | (853,160) | 576,310 | 267,443 | |
| 減：所得稅費用 | 143,033 | -8.28% | 260,559 | 138,290 | 318,443 | 308,731 | |
| 淨利潤 | 125,845 | -32.34% | (1,719,033) | (991,450) | 257,868 | (41,288) | |
| 減：非控股權益 | 79,628 | -18.35% | (29,088) | 35,519 | 164,572 | 247,243 | |
| 股東淨利潤 | 46,217 | -47.77% | (1,689,945) | (1,026,969) | 93,295 | (288,531) | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.018 | -45.34% | -0.642 | -0.391 | 0.036 | -0.110 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 1.154 | -33.47% | 1.092 | 1.705 | 2.117 | 2.137 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
